カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

乾燥症候群治療薬の世界市場2022：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他

◆英語タイトル：Global Sicca Syndrome Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19629 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

乾燥症候群治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の乾燥症候群治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

乾燥症候群治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の乾燥症候群治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Akari Therapeutics, Plc、Amgen Inc.、Ampio Pharmaceuticals, Inc.、Biogen, Inc.、Bristol-Myers Squibb Company、GlaxoSmithKline Plc、MedImmune, LLC、Novartis AG、Redx Pharma Plc、Toleranzia AB、UCB S.A.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、乾燥症候群治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な乾燥症候群治療薬メーカーの企業概要、2019年～2022年までの乾燥症候群治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な乾燥症候群治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別乾燥症候群治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの乾燥症候群治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での乾燥症候群治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および乾燥症候群治療薬の産業チェーンを掲載しています。
・第13、14、15章では、乾燥症候群治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 乾燥症候群治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の乾燥症候群治療薬市場規模・予測
- 世界の乾燥症候群治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Akari Therapeutics, Plc、Amgen Inc.、Ampio Pharmaceuticals, Inc.、Biogen, Inc.、Bristol-Myers Squibb Company、GlaxoSmithKline Plc、MedImmune, LLC、Novartis AG、Redx Pharma Plc、Toleranzia AB、UCB S.A.
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他
・用途別分析2017年-2028年：病院、診療所、その他
・乾燥症候群治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・乾燥症候群治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・乾燥症候群治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・乾燥症候群治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・乾燥症候群治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Sicca Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sicca Syndrome Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Sicca Syndrome Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While BMS-986142 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sicca Syndrome Drug include Akari Therapeutics, Plc, Amgen Inc., Ampio Pharmaceuticals, Inc., Biogen, Inc., and Bristol-Myers Squibb Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sicca Syndrome Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BMS-986142
Belimumab
Coversin
Filgotinib
LY-3090106
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Sicca Syndrome Drug market are listed below:
Akari Therapeutics, Plc
Amgen Inc.
Ampio Pharmaceuticals, Inc.
Biogen, Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
MedImmune, LLC
Novartis AG
Redx Pharma Plc
Toleranzia AB
UCB S.A.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sicca Syndrome Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sicca Syndrome Drug, with price, sales, revenue and global market share of Sicca Syndrome Drug from 2019 to 2022.
Chapter 3, the Sicca Syndrome Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sicca Syndrome Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sicca Syndrome Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sicca Syndrome Drug.
Chapter 13, 14, and 15, to describe Sicca Syndrome Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Sicca Syndrome Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sicca Syndrome Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 BMS-986142
1.2.3 Belimumab
1.2.4 Coversin
1.2.5 Filgotinib
1.2.6 LY-3090106
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sicca Syndrome Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sicca Syndrome Drug Market Size & Forecast
1.4.1 Global Sicca Syndrome Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sicca Syndrome Drug Sales in Volume (2017-2028)
1.4.3 Global Sicca Syndrome Drug Price (2017-2028)
1.5 Global Sicca Syndrome Drug Production Capacity Analysis
1.5.1 Global Sicca Syndrome Drug Total Production Capacity (2017-2028)
1.5.2 Global Sicca Syndrome Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sicca Syndrome Drug Market Drivers
1.6.2 Sicca Syndrome Drug Market Restraints
1.6.3 Sicca Syndrome Drug Trends Analysis
2 Manufacturers Profiles
2.1 Akari Therapeutics, Plc
2.1.1 Akari Therapeutics, Plc Details
2.1.2 Akari Therapeutics, Plc Major Business
2.1.3 Akari Therapeutics, Plc Sicca Syndrome Drug Product and Services
2.1.4 Akari Therapeutics, Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen Inc.
2.2.1 Amgen Inc. Details
2.2.2 Amgen Inc. Major Business
2.2.3 Amgen Inc. Sicca Syndrome Drug Product and Services
2.2.4 Amgen Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ampio Pharmaceuticals, Inc.
2.3.1 Ampio Pharmaceuticals, Inc. Details
2.3.2 Ampio Pharmaceuticals, Inc. Major Business
2.3.3 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product and Services
2.3.4 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biogen, Inc.
2.4.1 Biogen, Inc. Details
2.4.2 Biogen, Inc. Major Business
2.4.3 Biogen, Inc. Sicca Syndrome Drug Product and Services
2.4.4 Biogen, Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company Sicca Syndrome Drug Product and Services
2.5.4 Bristol-Myers Squibb Company Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Sicca Syndrome Drug Product and Services
2.6.4 GlaxoSmithKline Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 MedImmune, LLC
2.7.1 MedImmune, LLC Details
2.7.2 MedImmune, LLC Major Business
2.7.3 MedImmune, LLC Sicca Syndrome Drug Product and Services
2.7.4 MedImmune, LLC Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Sicca Syndrome Drug Product and Services
2.8.4 Novartis AG Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Redx Pharma Plc
2.9.1 Redx Pharma Plc Details
2.9.2 Redx Pharma Plc Major Business
2.9.3 Redx Pharma Plc Sicca Syndrome Drug Product and Services
2.9.4 Redx Pharma Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Toleranzia AB
2.10.1 Toleranzia AB Details
2.10.2 Toleranzia AB Major Business
2.10.3 Toleranzia AB Sicca Syndrome Drug Product and Services
2.10.4 Toleranzia AB Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 UCB S.A.
2.11.1 UCB S.A. Details
2.11.2 UCB S.A. Major Business
2.11.3 UCB S.A. Sicca Syndrome Drug Product and Services
2.11.4 UCB S.A. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sicca Syndrome Drug Breakdown Data by Manufacturer
3.1 Global Sicca Syndrome Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sicca Syndrome Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sicca Syndrome Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Sicca Syndrome Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Sicca Syndrome Drug Manufacturer Market Share in 2021
3.5 Global Sicca Syndrome Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sicca Syndrome Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sicca Syndrome Drug Market Size by Region
4.1.1 Global Sicca Syndrome Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Sicca Syndrome Drug Revenue by Region (2017-2028)
4.2 North America Sicca Syndrome Drug Revenue (2017-2028)
4.3 Europe Sicca Syndrome Drug Revenue (2017-2028)
4.4 Asia-Pacific Sicca Syndrome Drug Revenue (2017-2028)
4.5 South America Sicca Syndrome Drug Revenue (2017-2028)
4.6 Middle East and Africa Sicca Syndrome Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sicca Syndrome Drug Sales in Volume by Type (2017-2028)
5.2 Global Sicca Syndrome Drug Revenue by Type (2017-2028)
5.3 Global Sicca Syndrome Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sicca Syndrome Drug Sales in Volume by Application (2017-2028)
6.2 Global Sicca Syndrome Drug Revenue by Application (2017-2028)
6.3 Global Sicca Syndrome Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sicca Syndrome Drug Sales by Type (2017-2028)
7.2 North America Sicca Syndrome Drug Sales by Application (2017-2028)
7.3 North America Sicca Syndrome Drug Market Size by Country
7.3.1 North America Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Sicca Syndrome Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sicca Syndrome Drug Sales by Type (2017-2028)
8.2 Europe Sicca Syndrome Drug Sales by Application (2017-2028)
8.3 Europe Sicca Syndrome Drug Market Size by Country
8.3.1 Europe Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Sicca Syndrome Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sicca Syndrome Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Sicca Syndrome Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Sicca Syndrome Drug Market Size by Region
9.3.1 Asia-Pacific Sicca Syndrome Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sicca Syndrome Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sicca Syndrome Drug Sales by Type (2017-2028)
10.2 South America Sicca Syndrome Drug Sales by Application (2017-2028)
10.3 South America Sicca Syndrome Drug Market Size by Country
10.3.1 South America Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Sicca Syndrome Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sicca Syndrome Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Sicca Syndrome Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Sicca Syndrome Drug Market Size by Country
11.3.1 Middle East & Africa Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sicca Syndrome Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sicca Syndrome Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sicca Syndrome Drug
12.3 Sicca Syndrome Drug Production Process
12.4 Sicca Syndrome Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sicca Syndrome Drug Typical Distributors
13.3 Sicca Syndrome Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 乾燥症候群治療薬の世界市場2022：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他(Global Sicca Syndrome Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

乾燥症候群治療薬の世界市場2022：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp